{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:29:45Z","timestamp":1786739385063,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0 http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.4103\/nrr.nrr-d-25-01285","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:00:18Z","timestamp":1770008418000},"page":"4900-4901","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Crossroad of motor neuron disease and dementia: Insights from TDP-43 RNA-binding deficiency"],"prefix":"10.4103","volume":"21","author":[{"given":"Molly","family":"Magarotto","sequence":"first","affiliation":[{"name":"York Biomedical Research Institute, Department of Biology, University of York, Wentworth Way, Yorkshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7875-8661","authenticated-orcid":false,"given":"Han-Jou","family":"Chen","sequence":"additional","affiliation":[{"name":"York Biomedical Research Institute, Department of Biology, University of York, Wentworth Way, Yorkshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"R1-20260803","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuron.2021.10.033","article-title":"Developmental defects in Huntington\u2019s disease show that axonal growth and microtubule reorganization require NUMA1","volume":"110","author":"Capizzi","year":"2022","journal-title":"Neuron"},{"key":"R2-20260803","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1093\/brain\/awz313","article-title":"RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy","volume":"142","author":"Chen","year":"2019","journal-title":"Brain"},{"key":"R3-20260803","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","article-title":"TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD","volume":"21","author":"Chou","year":"2018","journal-title":"Nat Neurosci"},{"key":"R4-20260803","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jchemneu.2016.03.003","article-title":"Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"76","author":"Clark","year":"2016","journal-title":"J Chem Neuroanat"},{"key":"R5-20260803","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0061-22.2022","article-title":"Pathogenic mutation of TDP-43 impairs RNA processing in a cell type-specific manner: implications for the pathogenesis of ALS\/FTLD","volume":"9","author":"Imaizumi","year":"2022","journal-title":"eNeuro"},{"key":"R6-20260803","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp Mol Med"},{"key":"R7-20260803","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/hmg\/ddaf111","article-title":"Familial ALS\/FTD-associated RNA-binding deficient TDP-43 mutants cause neuronal and synaptic transcript dysregulation in vitro","volume":"34","author":"Magarotto","year":"2025","journal-title":"Hum Mol Genet"},{"key":"R8-20260803","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-023-00608-5","article-title":"The era of cryptic exons: implications for ALS-FTD","volume":"18","author":"Mehta","year":"2023","journal-title":"Mol Neurodegener"},{"key":"R9-20260803","doi-asserted-by":"crossref","first-page":"RP85921","DOI":"10.7554\/eLife.85921.3","article-title":"RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy","volume":"12","author":"Necarsulmer","year":"2023","journal-title":"Elife"},{"key":"R10-20260803","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","article-title":"Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43","volume":"130","author":"Walker","year":"2015","journal-title":"Acta Neuropathol"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-25-01285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:28:32Z","timestamp":1786735712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-25-01285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/nrr.nrr-d-25-01285","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"2025-08-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}